Prenatal Evaluation and Management of Fetuses Exposed to Anti-SSA/Ro Antibodies

Pediatric Cardiology, 06/04/2012

This report presents a discussion of the at–risk population, the spectrum of fetal cardiac disease associated with maternal anti–SSA antibodies, the current fetal echocardiographic screening tools, the therapeutic options, and the management and delivery planning strategies. With appropriate prenatal follow–up, assessment, and delivery planning, even high–risk fetuses can be delivered safely and managed effectively.

Print Article Summary Cat 2 CME Report